Overview
Li Lan practices in Shenzhen, China. Lan is rated as an Advanced expert by MediFind in the treatment of Mohr-Tranebjaerg Syndrome. Their top areas of expertise are Hearing Loss, Familial Deafness, Glomerulonephritis, Endoscopy, and Lung Transplant.
Their clinical research consists of co-authoring 379 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Mohr-Tranebjaerg Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hearing LossLan isDistinguished. Learn about Hearing Loss.
- Advanced
- Eosinophilic Esophagitis
- EsophagitisLan isAdvanced. Learn about Esophagitis.
- Familial DeafnessLan isAdvanced. Learn about Familial Deafness.
- GlomerulonephritisLan isAdvanced. Learn about Glomerulonephritis.
- Infant Hearing LossLan isAdvanced. Learn about Infant Hearing Loss.
- Lupus NephritisLan isAdvanced. Learn about Lupus Nephritis.
- Experienced
- Acoustic NeuromaLan isExperienced. Learn about Acoustic Neuroma.
- Acute PainLan isExperienced. Learn about Acute Pain.
- Acute PancreatitisLan isExperienced. Learn about Acute Pancreatitis.
- Adult Soft Tissue SarcomaLan isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AngiosarcomaLan isExperienced. Learn about Angiosarcoma.
- AppendectomyLan isExperienced. Learn about Appendectomy.